Latest Australian Government News

VanEck Investments Limited has released an updated Product Disclosure Statement detailing seven Australian fixed income ETFs listed on the ASX, offering investors diversified exposure across government bonds, corporate debt, and subordinated securities.

Astral Resources has completed a comprehensive in-fill drilling program at its flagship Theia Deposit within the Mandilla Gold Project, confirming robust high-grade gold mineralisation that underpins the Stage 1 starter pit. The results reinforce the project’s strong economic potential as it advances towards production.

Papyrus Australia reported a $112k net operating cash outflow in October 2025, offset by financing activities and R&D tax incentives, maintaining a runway of over five months. Despite a non-recurring legal expense and an investment write-down, the company remains confident in its operational continuity.

Urenco Limited has secured Foreign Investment Review Board approval for its strategic investment in Ubaryon, where Global Uranium and Enrichment Limited holds a significant stake, marking a key milestone in advancing innovative uranium enrichment technology.

Firebird Metals has secured a key patent for its energy-efficient kiln and announced plans for an Australian Demonstration Plant to commercialise its battery materials technology.

Race Oncology has received a $2.8 million Australian R&D tax refund for FY2025, with further overseas R&D rebates expected, bolstering its clinical development of innovative cancer therapies.

International Graphite Limited has finalized the purchase of industrial land in Collie, Western Australia, setting the stage for Australia’s first commercial graphite micronising facility amid rising global demand.

PPK Group reports record revenue at Craig International Ballistics and advances lithium sulfur battery technology, while preparing for a CEO transition and focusing on sovereign manufacturing.

Western Mines Group advances deep diamond drilling and a high-powered electromagnetic survey at its Mulga Tank project, leveraging co-funded grants to target high-grade nickel sulphide deposits.

Cleo Diagnostics has secured a $1.7 million R&D tax refund, strengthening its cash reserves to $5.75 million as it advances toward a pivotal US clinical trial and FDA submission for its ovarian cancer test.

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Macquarie Technology Group unveiled ambitious plans to expand its AI-optimised data centre footprint, supported by a $450 million debt facility and strong growth across its cloud, government cybersecurity, and telecom divisions.